Archive for 2008

Journal of Commercial Biotechnology — January 2009

The January 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 15, Issue 1 Editorial Biotechnology commercialisation: Getting past the technology-push PDF Yali Friedman Articles Record integrity and licensing your intellectual property PDF John Avellanet NIH assistance for new therapeutic […]


Instructor resources for Building Biotechnology

Last week I sent an update to my list of biotech educators about the availability of instructor resources for Building Biotechnology. I’m starting to see interest among educators who I didn’t email, so I ‘m posting a follow-up here to spread the word. The instructor resources are free for qualified educators and include figures and […]


Biotechnology and the Global Financial Crisis

Emergent biotechnology companies are very reliant on capital, often having less than two years capital on hand. Like other businesses with strong needs for cash, one would expect biotechnology companies to be adversely effected by a dearth of capital. The biotechnology financial crisis and request for pass-forward tax breaks have been covered elsewhere; I’ve been […]


Ranking International Biotechnology

I’m working on an International Biotechnology ranking and comparison for a well-known publication, and am looking for data sets comparing biotechnology activities in different countries as well as interesting anecdotes about successes/failures/challenges encountered in developing biotechnology in different countries as well between countries. If you’ve got comparative data sets or interesting anecdotes, please drop me […]


Spread your message with BiotechBlog

Post your content on BiotechBlog and have it syndicated across the web. Send me a pitch using the contact form. Guidelines for submissions are: BiotechBlog focuses on commercial, legal, political, and scientific trends in biotechnology. Your post should fit this framework. Posts should be action-oriented (case studies, best practices, guidelines, etc.) or otherwise insightful (perspectives, backgrounders, […]


Join the Journal of Commercial Biotechnology Discussion Group

Join the Journal of Commercial Biotechnology discussion group on LinkedIn: http://www.linkedin.com/groups?gid=1241807 This group focuses on the biotech industry. The audience and focus are the same as for the Journal of Commercial Biotechnology: Professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep […]


Slow Posting — New Project in the Works

Those who have been following this blog for long enough probably know what it means when posting slows down — it means that I’ve got a new project in the works. I’m currently working on a new online platform for biotechnology education. It should be ready for beta testing by December first, and formally launch […]


Drug Patent Expirations in November 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in November 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ALKERAN Glaxosmithkline melphalan hydrochloride 4,997,651 Nov 18, 2008 BREVIBLOC Baxter Hlthcare Corp esmolol hydrochloride 5,017,609 Nov 21, 2008 BUSPAR Bristol Myers Squibb buspirone hydrochloride 5,015,646 Nov 14, 2008 COVERA-HS Gd Searle […]


Journal of Commercial Biotechnology — October 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 14, Issue 4 Editorial Continuing education in biotechnology PDF Yali Friedman Articles Can compliance help marketing and business development? PDF John Avellanet Money for nothing? Risks in biopharmaceutical companies […]